News / Press Releases

: Press Releases

Press Releases

Tonix Pharmaceuticals to Present Breakthrough Therapy Designated-PTSD Program and Corporate Update at the 2017 BIO CEO & Investor Conference

February 9, 2017 • 7:00 AM EST

Tonix Pharmaceuticals to Present Breakthrough Therapy Designated-PTSD Program and Corporate Update at NobleCon13

January 24, 2017 • 7:00 AM EST

Tonix Pharmaceuticals Presented Details of Newly Expanded Product Development Pipeline at 9th Annual Biotech Showcase Conference

January 10, 2017 • 1:00 PM EST

Tonix Pharmaceuticals to Present Breakthrough Therapy Designated-PTSD Program and Corporate Update at 9th Annual Biotech Showcase Conference

January 3, 2017 • 7:00 AM EST

Tonix Pharmaceuticals’ PTSD Phase 3-Ready Drug Candidate, TNX-102 SL, Granted Breakthrough Therapy Designation by the FDA

December 19, 2016 • 7:00 AM EST

Tonix Pharmaceuticals Presented New Clinical Results from Sub-Group Analysis of Phase 2 AtEase Study in Military-Related Posttraumatic Stress Disorder (PTSD)

December 8, 2016 • 7:00 AM EST

Tonix Pharmaceuticals to Present Clinical Data at the 55th Annual Meeting of the American College of Neuropsychopharmacology (ACNP)

December 2, 2016 • 7:21 AM EST

Tonix Pharmaceuticals to Present at 9th Annual LD Micro Main Event Investor Conference

November 30, 2016 • 7:00 AM EST

Tonix Pharmaceuticals Reports Third Quarter 2016 Financial Results

November 10, 2016 • 4:30 PM EST

Tonix Pharmaceuticals to Present New Clinical Results from Retrospective Analysis of Phase 2 AtEase Study in Military-Related PTSD

November 10, 2016 • 7:00 AM EST

« Previous
1...
5
6
7
8
9
10
11
12
13
14
...27
Next »

Show All